Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|November 15, 2000

AccuImage qualifies for Over-the-Counter trading

AccuImage qualifies for Over-the-Counter tradingThe OTC Bulletin Board has authorized AccuImage Diagnostics to begin trading its stock on the OTCBB under "AIDP" as of Oct. 23. The San Francisco-based imaging company counts year-to-date income

AccuImage qualifies for Over-the-Counter trading

The OTC Bulletin Board has authorized AccuImage Diagnostics to begin trading its stock on the OTCBB under "AIDP" as of Oct. 23. The San Francisco-based imaging company counts year-to-date income of $252,096 and revenue of $2.3 million and claims that its revenue has more than doubled over the same period in 1999. AccuImage develops three-dimensional visualization software, including products that enable 3-D Web-based PACS review, and digital image distribution and archiving technologies. The company is actively pursuing strategic alliances with equipment vendors and broadband providers.

Related to this article

Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.